M. Ginestà

APC promoter is frequently methylated in pancreatic juice of patients with pancreatic carcinomas or periampullary tumors.

G. Capellá, T. Serrano, J. Busquets, 2016, Oncology letters.

Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.

F. Real, A. Look, G. Capellá, 2014, Gastroenterology.

VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects

M. Hidalgo, G. Capellá, R. Salazar, 2021, Journal for ImmunoTherapy of Cancer.

Tumor growth delay by adjuvant alternating electric fields which appears non-thermally mediated.

G. Capellá, A. Ivorra, Q. Castellví, 2015, Bioelectrochemistry.

Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model

G. Capellá, A. Figueras, F. Viñals, 2008, Molecular Cancer Therapeutics.

A climate-change attribution retrospective of some impactful weather extremes of 2021

D. Faranda, G. Messori, P. Yiou, 2022, Weather and Climate Dynamics.

Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11.

G. Capellá, R. Alemany, M. Cascalló, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Acute xenograft rejection, late xenograft rejection and long term survival xenografts in the hamster‐to‐rat heart transplantation model: histological characterisation under low‐dose of FK506

J. Figueras, E. Jaurrieta, D. Molleví, 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer.

V. Moreno, G. Capellá, José Costa, 2012, Clinical chemistry.

Metronomic chemotherapy following the maximum tolerated dose is an effective anti‐tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells

G. Capellá, F. Viñals, T. Serrano, 2013, International journal of cancer.